Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic leishmania infantum antigens with potential serodiagnosis applications

Clinical and Vaccine Immunology

Volumn 21, Issue 1, 2014, Pages 96-106

  Costa, Lourena E ^a   Lima, Mayara I S ^b   Chávez Fumagalli, Miguel A ^a   Menezes Souza, Daniel ^a   Martins, Vivian T ^a   Duarte, Mariana C ^a   Lage, Paula S ^a   Lopes, Eliane G P ^a   Lage, Daniela P ^a   Ribeiro, Tatiana G ^a   Andrade, Pedro H R ^a   De Magalhães Soares, Danielle F ^a   Soto, Manuel ^c   Tavares, Carlos A P ^a   Goulart, Luiz R ^a,d   Coelho, Eduardo A F ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM ANTIGEN; PARASITE ANTIGEN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIOPHAGE; BIOPANNING; BLOOD SAMPLING; CANINE EHRLICHIOSIS; CANINE VISCERAL LEISHMANIASIS; CHAGAS DISEASE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC TEST ACCURACY STUDY; DNA SEQUENCE; DOG; DOG DISEASE; EHRLICHIA CANIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LEISHMANIA INFANTUM; MALE; NONHUMAN; PHAGE DISPLAY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SUBTRACTIVE PHAGE DISPLAY SELECTION; TRYPANOSOMA CRUZI; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRAZIL; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; PEPTIDE LIBRARY; PEPTIDES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84892161570     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00583-13     Document Type: Article

References (67)

1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, WHO Leishmaniasis Control Team. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671. http://dx.doi.org/10.1371/ journal.pone.0035671.
2. Gramiccia M, Gradoni L. 2005. The current status of zoonotic leishmaniases and approaches to disease control. Int. J. Parasitol. 35: 1169-1180. http://dx.doi.org/10.1016/j.ijpara.2005.07.001.
3. Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L. 2008. Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. 24: 324-330. http://dx.doi.org/10.1016/j.pt.2008.04.001.
4. Cruz I, Acosta L, Gutiérrez MN, Nieto J, Cañavate C, Deschutter J, Bornay-Llinares FJ. 2010. A canine leishmaniasis pilot survey in an emerging focus of visceral leishmaniasis: Posadas (Misiones, Argentina). BMC Infect Dis. 10: 342-345. http://dx.doi.org/10.1186/1471-2334-10-342.
5. Duprey ZH, Steurer FJ, Rooney JA, Kirchhoff LV, Jackson JE, Rowton ED, Schantz PM. 2006. Canine visceral leishmaniasis, United States and Canada, 2000-2003. Emerg. Infect. Dis. 12: 440-446. http://dx.doi.org/10.1186/1471-2334- 10-342.
6. Shaw SE, Langton DA, Hillman TJ. 2009. Canine leishmaniosis in the United Kingdom: a zoonotic disease waiting for a vector? Vet. Parasitol. 163: 281-285. http://dx.doi.org/10.1016/j.vetpar.2009.03.025.
7. Figueiredo FB, Madeira MF, Nascimento LD, Abrantes TR, Mouta-Confort, Passos SR, Schubach TM. 2010. Canine visceral leishmaniasis: study of methods for the detection of IgG in serum and eluate samples. Rev. Inst. Med. Trop. São Paulo 52: 193-196. http://dx.doi.org/10.1590/S0036-46652010000400005.
8. Quinnell RJ, Courtenay O. 2009. Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology 136: 1915-1934. http://dx.doi.org/10.1017/S0031182009991156.
9. Silva DA, Madeira MF, Teixeira AC, de Souza CM, Figueiredo FB. 2011. Laboratory tests performed on Leishmania seroreactive dogs euthanized by the leishmaniasis control program. Vet. Parasitol. 179: 57-261. http://dx.doi.org/ 10.1016/j.vetpar.2011.01.052.
10. Troncarelli MZ, Camargo JB, Machado JG, Lucheis SB, Langoni H. 2009. Leishmania spp. and/or Trypanosoma cruzi diagnosis in dogs from endemic and nonendemic areas for canine visceral leishmaniasis. Vet. Parasitol. 164: 118-123. http://dx.doi.org/10.1016/j.vetpar.2009.06.027.
11. Viol MA, Lima VM, Aquino MC, Gallo G, Alves IP, Generoso D, Perri SH, Lucheis SB, Langoni H, Nunes CM, Bresciani KD. 2012. Detection of cross infections by Leishmaniaspp. and Trypanosomaspp. indogs using indirect immunoenzyme assay, indirect fluorescent antibody test and polymerase chain reaction. Parasitol. Res. 111: 1607-1613. http://dx.doi.org/10.1007/s00436-012- 2999-2.
12. Alves AS, Mouta-Confort E, Figueiredo FB, Oliveira RV, Schubach AO, Madeira MF. 2012. Evaluation of serological cross-reactivity between canine visceral leishmaniasis and natural infection by Trypanosoma caninum. Rev. Vet. Sci. 93: 1329-1333. http://dx.doi.org/10.1016/j.rvsc.2012.07.006.
13. Dantas-Torres F, de Paiva-Cavalcanti M, Figueredo LA, Melo MF, da Silva FJ, da Silva AL, Almeida EL, Brandão-Filho SP. 2010. Cutaneous and visceral leishmaniasis in dogs from a rural community in northeastern Brazil. Vet. Parasitol. 170: 313-317. http://dx.doi.org/10.1016/j.vetpar.2010.02.019.
14. de Sousa Oliveira TMF, Furuta PI, de Carvalho D, Machado RZ. 2008. A study of cross-reactivity in serum samples from dogs positive for Leishmania sp., Babesia canis and Ehrlichia canisin enzyme-linked immunosorbent assay and indirect fluorescent antibody test. Rev. Bras. Parasitol. 11: 7-11. (In Portuguese.)
15. Gomes APS, Cordeiro RLR. 2004. Reação cruzada no diagnóstico sorológicodeleishmaniose canina. Rev. Bras. Parasitol. 23: 162-166. (In Portuguese.)
16. Coelho EAF, Ramírez L, Costa MAF, Coelho VTS, Martins VT, Chávez-Fumagalli MA, Oliveira DM, Tavares CAP, Bonay P, Nieto CG, Abánades DR, Alonso C, Soto M. 2009. Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts. Clin. Vaccine Immunol. 16: 1774-1780. http://dx.doi.org/10.1128/CVI.00295-09.
17. Smith PG, Petrenko VA. 1997. Phage display. Chem. Rev. 97: 391-410. http://dx.doi.org/10.1021/cr960065d.
18. Barbas CF, III, Burton DR, Scott JK, Silverman GJ. 2001. Phage display: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
19. Wang LF, Yu M. 2004. Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Curr. Drug Targets 5: 1-15. http://dx.doi.org/10.2174/1389450043490668.
20. Germaschewski V, Murray K. 1995. Screening a monoclonal antibody with a fusion-phage display library shows a discontinuity in a linear epitope within PreS1 of hepatitis B virus. J. Med. Virol. 45: 300-305. http://dx.doi.org/10. 1002/jmv.1890450311.
21. Greenwood J, Willis A, Perham R. 1991. Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens. J. Mol. Biol. 220: 821-827.
22. Monette M, Opella S, Greenwood J, Willis A, Perham R. 2001. Structure of a malaria parasite antigenic determinant displayed on filamentous bacteriophage determined by NMR spectroscopy: implications for the structure of continuous peptide epitopes of proteins. Protein Sci. 10: 1150-1159. http://dx.doi.org/10. 1110/ps.35901.
23. Demangel C, Lafaye P, Mazie J. 1996. Reproducing the immune response against thePlasmodium vivaxmerozoite surface protein1with mimotopes selected from a phage-displayed peptide library. Mol. Immunol. 33: 909-916. http://dx.doi.org/10.1016/S0161-5890(96)00058-2.
24. Beghetto E, Spadoni A, Buffolano W, Del Pezzo M, Minenkova O, Pavoni E, Pucci A, Cortese R, Felici F, Gargano N. 2003. Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. Int. J. Parasitol. 33: 163-173. http://dx.doi.org/10.1016/S0020- 7519(02)00256-4.
25. Cunha-Júnior JP, Silva DA, Silva NM, Souza MA, Souza GR, Prudencio CR, Pirovani CP, Cezar M Cascardo J, Barbosa BF, Goulart LR, Mineo JR. 2010. A4D12 monoclonal antibody recognizes a new linear epitope from SAG2A Toxoplasma gondii tachyzoites, identified by phage display bioselection. Immunobiology 215: 26-37. http://dx.doi.org/10.1016/j.imbio.2009.01.008.
26. Pitcovsky TA, Mucci J, Alvarez P, Leguizamón MS, Burrone O, Alzari PM, Campetella O. 2001. Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants. Infect. Immun. 69: 1869-1875. http://dx.doi.org/10.1128/IAI.69.3.1869-1875.2001.
27. Bahia MT, Tafuri WL, Caliari MV, Veloso VM, Carneiro CM, Coelho GL, Lana M. 2002. Comparison of Trypanosoma cruzi infection in dogs inoculated with blood or metacyclic trypomastigotes of Berenice-62 and Berenice-78 strains via intraperitoneal and conjunctival routes. Rev. Soc. Bras. Med. Trop. 35: 339-345. http://dx.doi.org/10.1590/S0037-86822002000400010.
28. Carneiro CM, Martins-Filho OA, Reis AB, Veloso VM, Araújo FM, Bahia MT, de Lana M, Machado-Coelho GL, Gazzinelli G, Correa-Oliveira R, Tafuri WL. 2007. Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs. Acta Trop. 101: 120-129. http://dx.doi.org/10.1016/j.actatropica.2006.12.009.
29. Ramanakumar AV, Thomann P, Candeias JM, Villa LL, Franco EL. 2010. Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection. J. Clin. Microbiol. 48: 791-796. http://dx.doi.org/10.1128/JCM.00844-09.
30. Grubbs FE. 1969. Procedures for detecting outlying observations in samples. Technometrics 11: 1-21. http://dx.doi.org/10.1080/00401706.1969. 10490657.
31. Bi J, Lee HS, O'Mahony M. 2012. Statistical analysis of receiver operating characteristic (ROC) curves for the ratings of the A-not A and the same-different methods. J. Sens. Stud. 28: 34-46. http://dx.doi.org/10.1111/ joss.12021.
32. Youden WJ. 1950. Index for rating diagnostic tests. Cancer 3: 32-35. http://dx.doi.org/10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0. CO;2-3.
33. Cohen J. 1968. Weighted kappa: nominal scale agreement with provisions for scales disagreement of partial credit. Psychol. Bull. 70: 213-220. http://dx.doi.org/10.1037/h0026256.
34. Landis JR, Koch GG. 1977. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33: 363-374. http://dx.doi.org/10.2307/2529786.
35. Jayanna PK, Bedi D, Deinnocentes P, Bird RC, Petrenko VA. 2010. Landscape phage ligands for PC3 prostate carcinoma cells. Protein Eng. Des. Sel. 23: 423-430. http://dx.doi.org/10.1093/protein/gzq011.
36. Parmley SF, Smith GP. 1988. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 73: 305-318.
37. Scott JK, Smith GP. 1990. Searching for peptide ligands with an epitope library. Science 249: 386-390. http://dx.doi.org/10.1126/science.1696028.
38. Houimel M, Dellagi K. 2009. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity. Vaccine 27: 4648-4655. http://dx.doi.org/10.1016/j.vaccine.2009.05.055.
39. Roccasecca R, Folgori A, Ercole BB, Puntoriero G, Lahm A, Zucchelli S, Tafi R, Pezzanera M, Galfre G, Tramontano A, Mondelli MU, Pessi A, Nicosia A, Cortese R, Meola A. 2001. Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes. Mol. Immunol. 38: 485-492. http://dx.doi.org/10.1016/ S0161-5890(01)00084-0.
40. Ulises HC, Tatiana G, Karlen G, Guillermo MH, Juan XC, Carlos E. 2009. Peptide sequences identified by phage display are immunodominant functional motifs of Pet and Pic serine proteases secreted by Escherichia coli and Shigella flexneri. Peptides 30: 2127-2135. http://dx.doi.org/10.1016/j.peptides.2009.09. 019.
41. Wu HW, Hu XM, Wang Y, Kurtis JD, Zeng FJ, McGarvey ST, Wu GL, Zhang ZS, Hua ZC. 2006. Protective immunity induced by phage displayed mitochondrial related peptides of Schistosoma japonicum. Acta Trop. 99: 200-207. http://dx.doi.org/10.1016/j.actatropica.2006.08.006.
42. Marston EL, James AV, Parker JT, Hart JC, Brown TM, Messmer TO, Jue DL, Black CM, Carlone GM, Ades EW, Sampson J. 2002. Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies. Clin. Diagn. Lab. Immunol. 9: 446-452. http://dx.doi.org/10.1128/CDLI.9.2.446-452.2002.
43. Gazarian K, Rowlay M, Gazarian T, Vazquez Buchelli JE, Hernández Gonzáles M. 2012. Mimotope peptides selected from phage display combinatorial libraryby serum antibodies of pigs experimentally infected with Taenia solium as leads to developing diagnostic antigens for human neurocysticercosis. Peptides 38: 381-388. http://dx.doi.org/10.1016/j.peptides. 2012.09.021.
44. da Silva Ribeiro V, Manhani MN, Cardoso R, Vieira CU, Goulart LR, Costa-Cruz JM. 2010. Selection of high affinity peptide ligands for detection of circulating antibodies in neurocysticercosis. Immunol. Lett. 129: 94-99. http://dx.doi.org/10.1016/j.imlet.2010.01.008.
45. Manhani MN, Ribeiro VS, Cardoso R, Ueira-Vieira C, Goulart LR, Costa-Cruz JM. 2011. Specific phage-displayed peptides discriminate different forms of neurocysticercosis by antibody detection in the serum samples. Parasite Immunol. 33: 322-329. http://dx.doi.org/10.1111/j.1365-3024.2011.01283.x.
46. Iniguez P, Zientara S, Marault M, Machin JB, Hannant D, Cruciere C. Screening of horse polyclonal antibodies with a random peptide library displayed on phage: identification of ligands used as antigens in an ELISA test to detect the presence of antibodies to equine arteritis virus. J. Virol. Methods 73: 175-183. http://dx.doi.org/10.1016/S0166-0934(98)00057-3.
47. Yang L, Cen J, Xue Q, Li J, Bi Y, Sun L, Liu W. 2013. Identification of rabies virus mimotopes screened from a phage display peptide library with purified dog anti-rabies virus serum IgG. Virus Res. 174: 47-51. http://dx.doi.org/10.1016/j.virusres.2013.02.013.
48. Santos PS, Nascimento R, Rodrigues LP, Santos FAA, Faria PCB, Martins JRS, Brito-Madurro AG, Madurro JM, Goulart LR. 2012. Functional epitope core motif of the Anaplasma marginale major surface protein 1a and its incorporation onto bioelectrodes for antibody detection. PLoS One 7:e33045. http://dx.doi.org/10.1371/journal.pone.0033045.
49. Courtenay O, Quinnell RJ, Garcez LM, Shaw JJ, Dye C. 2002. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J. Infect. Dis. 186: 1314-1320. http://dx.doi.org/10.1086/344312.
50. Reis AB, Teixeira-Carvalho A, Vale AM, Marques MJ, Giunchetti RC, Mayrink W, Guerra LL, Andrade RA, Corrêa-Oliveira R, Martins-Filho AO. 2006. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi. Vet. Immunol. Immunopathol. 112: 102-116. http://dx.doi.org/10.1016/j. vetimm.2006.02.001.
51. Strauss-Ayali D, Jaffe CL, Burshtain O, Gonen L, Baneth G. 2004. Polymerase chain reaction using noninvasively obtained samples, for the detection of Leishmania infantum DNA in dogs. J. Infect. Dis. 189: 1729-1733. http://dx.doi.org/10.1086/383281.
52. Mettler M, Grimm F, Capelli G, Camp H, Deplazes D. 2005. Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs. J. Clin. Microbiol. 43: 5515-5519. http://dx.doi.org/10.1128/JCM.43.11.5515-5519. 2005.
53. De Bolle X, Laurent T, Tibor A, Godfroid F, Weynants V, Letesson JJ, Mertens P. 1999. Antigenic properties of peptidic mimics for epitopes of the lipopolysaccharide from Brucella. J. Mol. Biol. 294: 181-191. http://dx.doi.org/10.1006/jmbi.1999.3248.
54. Zucconi A, Dente L, Santonico E, Castagnoli L, Cesareni G. 2001. Selection of ligands by panning of domain libraries displayed on phage lambda reveals new potential partners of synaptojanin 1. J. Mol. Biol. 307: 1329-1339. http://dx.doi.org/10.1006/jmbi.2001.4572.
55. Rodi DJ, Soares AS, Makowski L. 2002. Quantitative assessment of peptide sequence diversity in M13 combinatorial peptide phage display libraries. J. Mol. Biol. 322: 1039-1052. http://dx.doi.org/10.1016/S0022-2836(02)00844-6.
56. Martins VT, Chávez-Fumagalli MA, Costa LE, Canavaci AM, Lage PS, Lage DP, Duarte MC, Valadares DG, Magalhães RD, Ribeiro TG, Nagem RA, Darocha WD, Régis WC, Soto M, Coelho EA, Fernandes AP, Tavares CA. 2013. Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis. PLoS Negl. Trop. Dis. 7: 1. http://dx.doi.org/10.1371/journal.pntd.0002148.
57. Carvalho FA, Charest H, Tavares CA, Matlashewski G, Valente EP, Rabello A, Gazzinelli RT, Fernandes AP. 2002. Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. Diagn. Microbiol. Infect. Dis. 43: 289-295. http://dx.doi.org/10.1016/ S0732-8893(02)00410-8.
58. Soto M, Requena JM, Quijada L, Alonso C. 1998. Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. J. Clin. Microbiol. 36: 58-63.
59. Boarino A, Scalone A, Gradoni L, Ferroglio E, Vitale F, Zanatta R, Giuffrida MG, Rosati S. 2005. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 12: 647-653. http://dx.doi.org/10.1128/CDLI.12.5.647-653.2005.
60. Chávez-Fumagalli MA, Martins VT, Testasicca MC, Lage DP, Costa LE, Lage PS, Duarte MC, Ker HG, Ribeiro TG, Carvalho FA, Régis WC, Dos Reis AB, Tavares CA, Soto M, Fernandes AP, Coelho EA. 2013. Sensitive and specific serodiagnosis of Leishmania infantum infection in dogsby using peptides selected from hypothetical proteins identifiedbyan immunoproteomic approach. Clin. Vaccine Immunol. 20: 835-841. http://dx.doi.org/10.1128/CVI.00023-13.
61. Costa MM, Penido M, dos Santos MS, Doro D, de Freitas E, Michalick MSM, Grimaldi G, Gazzinelli RT, Fernandes AP. 2012. Improved canine and human visceral leishmaniasis immunodiagnosis using combinations of synthetic peptides in enzyme-linked immunosorbent assay. PLoS Negl. Trop. Dis. 6:e1622. http://dx.doi.org/10.1371/journal.pntd.0001622.
62. Faria AR, Costa MM, Giusta MS, Grimaldi G, Jr, Penido MLO, Gazzinelli RT, Andrade HM. 2011. High-throughput analysis of synthetic peptides for the immunodiagnosis of canine visceral leishmaniasis. PLoS Negl. Trop. Dis. 5:e1310. http://dx.doi.org/10.1371/journal.pntd.0001310.
63. Marcondes M, Biondo AW, Gomes AA, Silva AR, Vieira RF, Camacho AA, Quinn J, Chandrashekar R. 2011. Validation of a Leishmania infantum ELISA rapid test for serological diagnosis of Leishmania chagasi in dogs. Vet. Parasitol. 175: 15-19. http://dx.doi.org/10.1016/j.vetpar.2010.09.036.
64. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. 2003. The diagnostic odds ratio: a single indicator of test performance. J. Clin. Epidemiol. 56: 1129-1135. http://dx.doi.org/10.1016/S0895-4356(03)00177-X.
65. Rodríguez-Cortés A, Ojeda A, Todolí F, Alberola J. 2013. Performance of commercially available serological diagnostic tests to detect Leishmania infantum infection on experimentally infected dogs. Vet. Parasitol. 191: 363-366. http://dx.doi.org/10.1016/j.vetpar.2012.09.009.
66. Coura-Vital W, Marques MJ, Veloso VM, Roatt BM, Aguiar-Soares RD, Reis LE, Braga SL, Morais MH, Reis AB, Carneiro M. 2011. Prevalence and factors associated withLeishmania infantum infection of dogs from an urban area of Brazil as identified by molecular methods. PLoS Negl. Trop. Dis. 5:e1291. http://dx.doi.org/10.1371/journal.pntd.0001291.
67. Collins J. 1997. Phage display. Annu. Rep. Comb. Chem. Mol. Divers. 1: 210-262.